Julian Schulze-Zur-Wiesch

30PUBLICATIONS
107CO-AUTHORS
Predictive and prognostic markersPreventative health careRehabilitationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Aug 12, 2026
FGL-1 plasma levels correlate with markers of inflammation and severe disease during SARS-CoV-2 infection.

|Oct 25, 2025
Five-Year German PrEP cohort reveals high HIV protection and persistent STI burden: implications for individualized and flexible prevention strategies.

Maher Almahfoud, Lukas Weimann, Guido Schäfer

|Jul 08, 2025
Long-Term Real-World Use of Cabotegravir/Rilpivirine: Adherence and Virological Efficacy over a 44-Month Observation Period.

Catharina Dannenberg, Hanna Matthews, Anja Hüfner

|Jan 08, 2025
Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Recipients.

Philippa von der Schulenburg, Georg M N Behrens, Markus Hoffmann

|Jul 31, 2024
B cells expressing mutated IGHV1-69-encoded antigen receptors related to virus neutralization show lymphoma-like transcriptomes in patients with chronic HCV infection.

Christoph Schultheiß, Edith Willscher, Lisa Paschold

|Jan 27, 2024
High vaccination coverage and infection rate result in a robust SARS-CoV-2-specific immunity in the majority of liver cirrhosis and transplant patients: A single-center cross-sectional study.

P von der Schulenburg, A Herting, A Harberts

Pageof 5

Frequent Collaborators

11 joint publications

Marylyn Martina Addo

4 joint publications

Samuel Huber

4 joint publications

Leon Cords

4 joint publications

Marc Lütgehetmann